These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34908156)

  • 1. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
    Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
    Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
    Qureshi Z; Ahmad M; Yang WX; Tan FQ
    Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-canonical Small GTPase RBJ Promotes NSCLC Progression Through the Canonical MEK/ERK Signaling Pathway.
    Wang Y; Shen X; Wang Q; Guo Z; Hu L; Dong Z; Hu W
    Curr Pharm Des; 2022; 28(42):3446-3455. PubMed ID: 36397632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.
    Zhang H; Li C; Liao S; Tu Y; Sun S; Yao F; Li Z; Wang Z
    Cancer Biol Ther; 2022 Dec; 23(1):1-11. PubMed ID: 36137220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
    Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
    Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
    Wang J; Guo X; Xie C; Jiang J
    Br J Cancer; 2017 Jul; 117(2):245-255. PubMed ID: 28595260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIF15 knockdown inhibits the development of endometrial cancer by suppressing epithelial-mesenchymal transition and stemness through Wnt/β-catenin signaling.
    Huang J; Sun X; Diao G; Li R; Guo J; Han J
    Environ Toxicol; 2023 Aug; 38(8):1824-1834. PubMed ID: 37186152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
    Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway.
    Ren M; Xu W; Xu T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1014-1021. PubMed ID: 30880481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of
    Zhang P; Li Z; Yang G
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aloe emodin 3-O-glucoside inhibits cell growth and migration and induces apoptosis of non-small-cell lung cancer cells via suppressing MEK/ERK and Akt signalling pathways.
    Kim HJ; Choi JW; Ree J; Lim JS; Lee J; Kim JI; Thapa SB; Sohng JK; Park YI
    Life Sci; 2022 Jul; 300():120495. PubMed ID: 35341826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
    Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
    Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.
    Cai Y; Lai Q; Zhang X; Zhang Y; Zhang M; Gu S; Qin Y; Hou J; Zhao L
    Korean J Physiol Pharmacol; 2023 Sep; 27(5):457-470. PubMed ID: 37641808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
    Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
    Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.